Total Funding
65
60
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
27061
Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.
- William P. Kane: President and CEOPast Role: Karuna Therapeutics, CCO
About the Company
Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines, particularly in immunology and inflammation. The company utilizes leadership from experienced pharmaceutical executives to effectively drive its research and development efforts. Uniquity Bio has been backed by
investments from notable entities, helping it to pursue its innovative drug development goals.
